Banner
HomeFocus → Brilinta or Clopidogrel, Maximum Benefit or Social Responsibility?

Brilinta or Clopidogrel, Maximum Benefit or Social Responsibility? Print E-mail
Written by FHI's Week in Review   
Monday, 09 April 2018 11:40

An April 7 A Country Doctor Writes blog post illustrates the dilemma faced by American healthcare providers in this examination of the costs and benefits associated with two different prescription medicines used to prevent cardiovascular events.

Read more in the current issue of Week in Review>> https://conta.cc/2IHcGqr
 


Banner
Website design, development, and hosting provided by
Netphiles